HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

manganese (III) meso- tetrakis(N- ethylpyridinium- 2- yl)porphyrin

structure in first source
Also Known As:
AEOL10113; Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl)porphyrin; MnT2E; MnTE-2-PyP5+
Networked: 6 relevant articles (3 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Batinic-Haberle, Ines: 4 articles (01/2021 - 03/2008)
2. Sheng, Huaxin: 2 articles (01/2021 - 02/2006)
3. Spasojevic, Ivan: 2 articles (01/2021 - 11/2018)
4. Tovmasyan, Artak: 2 articles (01/2021 - 11/2018)
5. Crapo, James D: 2 articles (02/2006 - 05/2003)
6. Alvarez Secord, Angeles: 1 article (01/2021)
7. Cao, Zhipeng: 1 article (01/2021)
8. Du, Li: 1 article (01/2021)
9. Duan, Weina: 1 article (01/2021)
10. Huang, Zhiqing: 1 article (01/2021)

Related Diseases

1. Lung Injury
2. Ischemia
3. Cardiac Arrhythmias (Arrythmia)
4. Myocardial Ischemia (Ischemic Heart Diseases)
5. Head and Neck Neoplasms (Head and Neck Cancer)

Related Drugs and Biologics

1. Anti-Arrhythmia Agents
2. Mn(III) ortho- tetrakis(N- hexylpyridinium- 2- yl)porphyrin
3. Porphyrins
4. Glutathione Disulfide (GSSG)
5. Proteins (Proteins, Gene)
6. Aconitate Hydratase (Aconitase)

Related Therapies and Procedures

1. Subcutaneous Injections